Michael Levy, director of the Food and Drug Administration's (FDA) division of new drugs and labeling compliance, testifies on Capitol Hill in Washington, Tuesday, Sept. 29, 2009, before a Senate Judiciary subcommittee hearing on dietary supplements. AP Photo logo AP Photo 29 months ago

Michael Levy, director of the Food and Drug Administration's (FDA) division of new drugs and labeling compliance, testifies on Capitol Hill in Washington, Tuesday, Sept. 29, 2009, before a Senate Judiciary subcommittee hearing on dietary supplements.